Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 2

Author(s): Juliette Raffort, Fabien Lareyre, Niki Katsiki* and Dimitri P Mikhailidis

Volume 20, Issue 1, 2022

Published on: 08 July, 2021

Page: [16 - 26] Pages: 11

DOI: 10.2174/1570161119666210708165748

Price: $65

Abstract

This is Part 2 of a narrative review summarizing the literature on CIN after non-cardiac vascular diagnostic or therapeutic procedures, focusing on Peripheral Artery Disease (PAD) and Renal Artery Stenosis (RAS). Part 1 discussed CIN in relation to aortic aneurysms and carotid stenosis. We comment on the incidence, biomarkers, risk factors and consequences of CIN in patients with PAD or RAS, as well as on strategies to prevent CIN. Future perspectives in the field of CIN in relation to non-cardiac vascular procedures are also considered.

Keywords: Contrast-induced nephropathy, non-cardiac vascular procedure, peripheral artery disease, renal artery stenosis, carotid stenosis, aortic aneurysms.

« Previous Next »
[1]
McCullough PA, Choi JP, Feghali GA, et al. Contrast-Induced Acute Kidney Injury. J Am Coll Cardiol 2016; 68(13): 1465-73.
[http://dx.doi.org/10.1016/j.jacc.2016.05.099] [PMID: 27659469]
[2]
Seeliger E, Sendeski M, Rihal CS, Persson PB. Contrast-induced kidney injury: Mechanisms, risk factors, and prevention. Eur Heart J 2012; 33(16): 2007-15.
[http://dx.doi.org/10.1093/eurheartj/ehr494] [PMID: 22267241]
[3]
James MT, Samuel SM, Manning MA, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: A systematic review and meta-analysis. Circ Cardiovasc Interv 2013; 6(1): 37-43.
[http://dx.doi.org/10.1161/CIRCINTERVENTIONS.112.974493] [PMID: 23322741]
[4]
McCullough PA. Contrast-Induced Nephropathy: Definitions, Epidemiology, and Implications. Interv Cardiol Clin 2014; 3(3): 357-62.
[PMID: 28582220]
[5]
McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51(15): 1419-28.
[http://dx.doi.org/10.1016/j.jacc.2007.12.035] [PMID: 18402894]
[6]
Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Contrast-Induced Nephropathy: An “All or None” Phenomenon? Angiology 2015; 66(6): 508-13.
[http://dx.doi.org/10.1177/0003319714550309] [PMID: 25225196]
[7]
Uzunhasan I, Yildiz A, Arslan S, et al. Contrast-induced acute kidney injury is associated with long-term adverse events in patients with acute coronary syndrome. Angiology 2017; 68(7): 621-6.
[http://dx.doi.org/10.1177/0003319716676173] [PMID: 28660805]
[8]
Sun G, Chen P, Wang K, et al. Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction. Angiology 2019; 70(7): 621-6.
[http://dx.doi.org/10.1177/0003319718803677] [PMID: 30317864]
[9]
Azzalini L, Kalra S. Contrast-induced acute kidney injury-definitions, epidemiology, and implications. Interv Cardiol Clin 2020; 9(3): 299-309.
[http://dx.doi.org/10.1016/j.iccl.2020.02.001] [PMID: 32471671]
[10]
Paraskevas KI, Mikhailidis DP. Contrast-induced acute kidney injury in patients undergoing carotid artery stenting: An underestimated issue. Angiology 2017; 68(9): 752-6.
[http://dx.doi.org/10.1177/0003319716668934] [PMID: 27645233]
[11]
Paraskevas KI, Geroulakos G, Vlahakos DV. Contrast-induced nephropathy after endovascular aneurysm repair, carotid and peripheral interventions. Curr Vasc Pharmacol 2020; 18(5): 531-2.
[http://dx.doi.org/10.2174/1570161117999190821145924] [PMID: 31455200]
[12]
Raffort J, Lareyre F, Katsiki N, Mikhailidis DP. Contrast-induced nephropathy in non-cardiac vascular procedures: A narrative review Part 1. Curr Vasc Pharmacol 2021.
[13]
Martínez-Rico C, Martí-Mestre X, Romera-Villegas A, Espinar-Garcia E, Iborra-Ortega E, Vila-Coll R. Contrast-induced nephropathy: A fact or fiction in lower limb revascularization? Ann Vasc Surg 2017; 44: 277-81.
[http://dx.doi.org/10.1016/j.avsg.2017.03.193] [PMID: 28479456]
[14]
Al Adas Z, Lodewyk K, Robinson D, et al. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction. J Vasc Surg 2019; 69(3): 913-20.
[http://dx.doi.org/10.1016/j.jvs.2018.06.196] [PMID: 30292616]
[15]
Sigterman TA, Krasznai AG, Snoeijs MG, Heijboer R, Schurink GW, Bouwman LH. Contrast induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease. Eur J Vasc Endovasc Surg 2016; 51(3): 386-93.
[http://dx.doi.org/10.1016/j.ejvs.2015.08.023] [PMID: 26460289]
[16]
Vuruşkan E, Saraçoğlu E. Bilirubin levels are associated with contrast-induced nephropathy in peripheral artery disease. Angiology 2017; 68(8): 728-33.
[http://dx.doi.org/10.1177/0003319716679340] [PMID: 27852844]
[17]
Kroneberger C, Enzweiler CN, Schmidt-Lucke A, Rückert RI, Teichgräber U, Franiel T. Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease. Acta Radiol Open 2015; 4(6): 2058460115583034.
[http://dx.doi.org/10.1177/2058460115583034] [PMID: 26346218]
[18]
Grossman PM, Ali SS, Aronow HD, et al. Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the blue cross blue shield of michigan cardiovascular consortium. J Interv Cardiol 2017; 30(3): 274-80.
[http://dx.doi.org/10.1111/joic.12379] [PMID: 28370487]
[19]
Kim GS, Ko YG, Shin DH, et al. Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy. J Vasc Surg 2015; 61(5): 1223-30.
[http://dx.doi.org/10.1016/j.jvs.2014.11.079] [PMID: 25595408]
[20]
Cury MVM, Matielo MF, Brochado Neto FC, et al. The incidence, risk factors, and outcomes of contrast-induced nephropathy in patients with critical limb ischemia following lower limb angiography. Angiology 2018; 69(8): 700-8.
[http://dx.doi.org/10.1177/0003319718754984] [PMID: 29390867]
[21]
El-Hajjar M, Bashir I, Khan M, Min J, Torosoff M, DeLago A. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures. Am J Cardiol 2008; 102(3): 353-6.
[http://dx.doi.org/10.1016/j.amjcard.2008.03.067] [PMID: 18638601]
[22]
Goel SS, Shishehbor MH. Renal complications in patients undergoing peripheral artery interventions. Interv Cardiol Clin 2014; 3(3): 441-8.
[http://dx.doi.org/10.1016/j.iccl.2014.03.012] [PMID: 28582228]
[23]
Lee SR, Zhuo H, Zhang Y, Dahl N, Dardik A, Ochoa Chaar CI. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions. J Vasc Surg 2020; 72(2): 603-610.e1.
[http://dx.doi.org/10.1016/j.jvs.2019.09.059] [PMID: 31843298]
[24]
Prasad A, Ortiz-Lopez C, Khan A, Levin D, Kaye DM. Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature. Catheter Cardiovasc Interv 2016; 88(2): 264-73.
[http://dx.doi.org/10.1002/ccd.26466] [PMID: 26946253]
[25]
Zlatanovic P, Koncar I, Dragas M, et al. Combined impact of chronic kidney disease and contrast induced acute kidney injury on long-term outcomes in patients with acute lower limb ischaemia. Eur J Vasc Endovasc Surg 2018; 56(1): 78-86.
[http://dx.doi.org/10.1016/j.ejvs.2018.03.008] [PMID: 29636253]
[26]
Yang Y, Zhao X, Tang X, et al. Comparison of serum cystatin C and creatinine level changes for prognosis of patients after peripheral arterial angiography. Angiology 2015; 66(8): 766-73.
[http://dx.doi.org/10.1177/0003319714555431] [PMID: 25344529]
[27]
Kabeer MA, Cross J, Hamilton G, Rashid ST. Obesity as a risk factor for radiographic contrast-induced nephropathy. Angiology 2021; 72(3): 274-8.
[http://dx.doi.org/10.1177/0003319720969536] [PMID: 33228378]
[28]
Aboyans V, Desormais I, Magne J, Morange G, Mohty D, Lacroix P. Renal artery stenosis in patients with peripheral artery disease: Prevalence, risk factors and long-term prognosis. Eur J Vasc Endovasc Surg 2017; 53(3): 380-5.
[http://dx.doi.org/10.1016/j.ejvs.2016.10.029] [PMID: 27919610]
[29]
Kanbay M, Solak Y, Afsar B, et al. Serum uric acid and risk for acute kidney injury following contrast. Angiology 2017; 68(2): 132-44.
[http://dx.doi.org/10.1177/0003319716644395] [PMID: 27106252]
[30]
Katsiki N, Karagiannis A, Mikhailidis DP. Diabetes, bilirubin and amputations: Is there a link? Diabetologia 2013; 56(4): 683-5.
[http://dx.doi.org/10.1007/s00125-013-2840-1] [PMID: 23354127]
[31]
Wu YH, Wu CY, Cheng CY, Tsai SF. Severe hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography. PLoS One 2020; 15(4): e0231264.
[http://dx.doi.org/10.1371/journal.pone.0231264] [PMID: 32294106]
[32]
Sadat U, Walsh SR, Norden AG, Gillard JH, Boyle JR. Does oral N-acetylcysteine reduce contrast-induced renal injury in patients with peripheral arterial disease undergoing peripheral angiography? A randomized-controlled study. Angiology 2011; 62(3): 225-30.
[http://dx.doi.org/10.1177/0003319710377078] [PMID: 20682612]
[33]
Berwanger O, Cavalcanti AB, Sousa AM, et al. Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: A substudy of the acetylcysteine for contrast-induced nephropathy trial. Circ Cardiovasc Interv 2013; 6(2): 139-45.
[http://dx.doi.org/10.1161/CIRCINTERVENTIONS.112.000149] [PMID: 23572490]
[34]
O’Sullivan S, Healy DA, Moloney MC, Grace PA, Walsh SR. The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: A structured review and meta-analysis. Angiology 2013; 64(8): 576-82.
[http://dx.doi.org/10.1177/0003319712467223] [PMID: 23188834]
[35]
Katsiki N, Giannoukas AD, Athyros VG, Mikhailidis DP. Lipid-lowering treatment in peripheral artery disease. Curr Opin Pharmacol 2018; 39: 19-26.
[http://dx.doi.org/10.1016/j.coph.2018.01.003] [PMID: 29413998]
[36]
Katsiki N, Triposkiadis F, Giannoukas AD, Mikhailidis DP. Statin loading in cardiovascular surgery: Never too early to treat. Curr Opin Cardiol 2018; 33(4): 436-43.
[http://dx.doi.org/10.1097/HCO.0000000000000519] [PMID: 29601328]
[37]
Han Y, Zhu G, Han L, et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J Am Coll Cardiol 2014; 63(1): 62-70.
[http://dx.doi.org/10.1016/j.jacc.2013.09.017] [PMID: 24076297]
[38]
Zhang J, Li Y, Tao GZ, et al. Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: A sub-analysis of the TRACK-D study. Chin Med J (Engl) 2015; 128(6): 784-9.
[http://dx.doi.org/10.4103/0366-6999.152620] [PMID: 25758273]
[39]
Bolt LJJ, Sigterman TA, Krasznai AG, Sikkink CJM, Schurink GH, Bouwman LH. Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: Study protocol for a randomised controlled trial. BMJ Open 2018; 8(9): e021842.
[http://dx.doi.org/10.1136/bmjopen-2018-021842] [PMID: 30287607]
[40]
Almutairi A, Sun Z, Poovathumkadavi A, Assar T. Dual energy CT angiography of peripheral arterial disease: Feasibility of using lower contrast medium volume. PLoS One 2015; 10(9): e0139275.
[http://dx.doi.org/10.1371/journal.pone.0139275] [PMID: 26418007]
[41]
Özgen A, Sanioğlu S, Bingöl UA. Intra-arterial ultra-low-dose CT angiography of lower extremity in diabetic patients. Cardiovasc Intervent Radiol 2016; 39(8): 1165-9.
[http://dx.doi.org/10.1007/s00270-016-1358-6] [PMID: 27150802]
[42]
Hayakawa N, Kodera S, Ohki N, Kanda J. Efficacy and safety of endovascular therapy by diluted contrast digital subtraction angiography in patients with chronic kidney disease. Heart Vessels 2019; 34(11): 1740-7.
[http://dx.doi.org/10.1007/s00380-019-01412-2] [PMID: 30989328]
[43]
Prasad A, Ortiz-Lopez C, Kaye DM, et al. The use of the AVERT system to limit contrast volume administration during peripheral angiography and intervention. Catheter Cardiovasc Interv 2015; 86(7): 1228-33.
[http://dx.doi.org/10.1002/ccd.26155] [PMID: 26389534]
[44]
Bates KM, Ghanem H, Hague J, Matheiken SJ. Standardisation of technique and volume of iodinated contrast administration during infrainguinal angioplasty. Curr Pharm Des 2019; 25(44): 4667-74.
[http://dx.doi.org/10.2174/1381612825666191209123821] [PMID: 31814551]
[45]
Lin J, Li D, Yan F. High-resolution 3D contrast-enhanced MRA with parallel imaging techniques before endovascular interventional treatment of arterial stenosis. Vasc Med 2009; 14(4): 305-11.
[http://dx.doi.org/10.1177/1358863X09104224] [PMID: 19808715]
[46]
Schneider G, Ballarati C, Grazioli L, et al. Gadobenate dimeglumine-enhanced MR angiography: Diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography. J Magn Reson Imaging 2007; 26(4): 1020-32.
[http://dx.doi.org/10.1002/jmri.21127] [PMID: 17896354]
[47]
Bolt LJJ, Krasznai AG, Sigterman TA, Sikkink CJJM, Schurink GWH, Bouwman LH. Duplex-guided versus conventional percutaneous transluminal angioplasty of iliac TASC II A and B lesion: A randomized controlled trial. Ann Vasc Surg 2019; 55: 138-47.
[http://dx.doi.org/10.1016/j.avsg.2018.07.047] [PMID: 30287297]
[48]
Ascher E, Marks NA, Schutzer RW, Hingorani AP. Duplex-guided balloon angioplasty and stenting for femoropopliteal arterial occlusive disease: An alternative in patients with renal insufficiency. J Vasc Surg 2005; 42(6): 1108-13.
[http://dx.doi.org/10.1016/j.jvs.2005.08.024] [PMID: 16376200]
[49]
Krasznai AG, Sigterman TA, Welten RJ, et al. Duplex-guided percutaneous transluminal angioplasty in iliac arterial occlusive disease. Eur J Vasc Endovasc Surg 2013; 46(5): 583-7.
[http://dx.doi.org/10.1016/j.ejvs.2013.08.011] [PMID: 24055119]
[50]
Ghumman SS, Weinerman J, Khan A, et al. Contrast induced-acute kidney injury following peripheral angiography with carbon dioxide versus iodinated contrast media: A meta-analysis and systematic review of current literature. Catheter Cardiovasc Interv 2017; 90(3): 437-48.
[http://dx.doi.org/10.1002/ccd.27051] [PMID: 28463460]
[51]
Stegemann E, Tegtmeier C, Bimpong-Buta NY, et al. Carbondioxide-aided angiography decreases contrast volume and preserves kidney function in peripheral vascular interventions. Angiology 2016; 67(9): 875-81.
[http://dx.doi.org/10.1177/0003319715614701] [PMID: 26535013]
[52]
Fujihara M, Kawasaki D, Shintani Y, et al. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: A prospective multicenter trial of CO2 angiography registry. Catheter Cardiovasc Interv 2015; 85(5): 870-7.
[http://dx.doi.org/10.1002/ccd.25722] [PMID: 25380326]
[53]
Gupta A, Dosekun AK, Kumar V. Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy. World J Cardiol 2020; 12(2): 76-90.
[http://dx.doi.org/10.4330/wjc.v12.i2.76] [PMID: 32184976]
[54]
Jakobi T, Meyborg M, Freisinger E, et al. Feasibility and impact of carbon dioxide angiography on acute kidney injury following endovascular interventions in patients with peripheral artery disease and renal impairment. J Nephrol 2021; 34(3): 811-20. Epub ahead of print
[http://dx.doi.org/10.1007/s40620-020-00909-8] [PMID: 33555574]
[55]
Morganti A. Angioplasty of the renal artery: Antihypertensive and renal effects. J Nephrol 2000; 13(Suppl. 3): S28-33.
[PMID: 11132030]
[56]
Trani C, Porto I, Tommasino A, et al. Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study. Int J Cardiol 2013; 167(3): 1006-11.
[http://dx.doi.org/10.1016/j.ijcard.2012.03.078] [PMID: 22503569]
[57]
Takahashi EA, Kallmes DF, Fleming CJ, et al. Predictors and outcomes of postcontrast acute kidney injury after endovascular renal artery intervention. J Vasc Interv Radiol 2017; 28(12): 1687-92.
[http://dx.doi.org/10.1016/j.jvir.2017.07.038] [PMID: 28947366]
[58]
Albertal M, Nau G, Padilla LT, Cura FA, Thierer J, Belardi JA. Do men and women respond differently to percutaneous renal artery interventions? Angiology 2010; 61(2): 216-21.
[http://dx.doi.org/10.1177/0003319709337306] [PMID: 19759030]
[59]
Lufft V, Hoogestraat-Lufft L, Fels LM, et al. Contrast media nephropathy: Intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: A prospective randomized trial. Am J Kidney Dis 2002; 40(2): 236-42.
[http://dx.doi.org/10.1053/ajkd.2002.34501] [PMID: 12148095]
[60]
Saad A, Wang W, Herrmann SM, et al. Atherosclerotic renal artery stenosis is associated with elevated cell cycle arrest markers related to reduced renal blood flow and postcontrast hypoxia. Nephrol Dial Transplant 2016; 31(11): 1855-63.
[http://dx.doi.org/10.1093/ndt/gfw265] [PMID: 27474749]
[61]
Ahuja TS, Niaz N, Agraharkar M. Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 2000; 54(1): 11-4.
[PMID: 10939751]
[62]
Lee SR, Dardik A, Ochoa Chaar CI. Postcontrast acute kidney injury after peripheral vascular interventions in kidney transplant recipients. Ann Vasc Surg 2020; 68: 8-14.
[http://dx.doi.org/10.1016/j.avsg.2020.04.057] [PMID: 32428641]
[63]
Tsao CR, Liu TJ, Chen FC, et al. Intravenous aminophylline provides no additional renal protection in patient with severe atherosclerotic renal artery stenosis treated by delicate percutaneous renal intervention. Int J Cardiol 2006; 110(1): 122-4.
[http://dx.doi.org/10.1016/j.ijcard.2005.06.013] [PMID: 16005532]
[64]
Duranay M, Kanbay M, Akay H, et al. Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: A pilot study. Nephron Clin Pract 2010; 114(3): c213-7.
[http://dx.doi.org/10.1159/000262304] [PMID: 19955827]
[65]
Peng M, Dong H, Jiang X, et al. A randomized unblinded trial to compare effects of intensive versus conventional lipid-lowering therapy in patients undergoing renal artery stenting. J Cardiol 2019; 74(5): 443-50.
[http://dx.doi.org/10.1016/j.jjcc.2019.04.010] [PMID: 31235418]
[66]
Vassallo D, Ritchie J, Green D, Chrysochou C, Blunt J, Kalra PA. The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study. BMC Nephrol 2016; 17(1): 198.
[http://dx.doi.org/10.1186/s12882-016-0409-1] [PMID: 27927187]
[67]
Zeller T, Bonvini RF, Sixt S. Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization. Catheter Cardiovasc Interv 2008; 71(7): 995-9.
[http://dx.doi.org/10.1002/ccd.21525] [PMID: 18383154]
[68]
Harb TS, Laird JR, Dieter RS, et al. Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency. J Endovasc Ther 2004; 11(5): 553-9.
[http://dx.doi.org/10.1583/04-1234.1] [PMID: 15482029]
[69]
Kane GC, Stanson AW, Kalnicka D, et al. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: Clinical outcomes. Nephrol Dial Transplant 2008; 23(4): 1233-40.
[http://dx.doi.org/10.1093/ndt/gfm725] [PMID: 18256017]
[70]
Kawasaki D, Fujii K, Fukunaga M, et al. Safety and efficacy of carbon dioxide and intravascular ultrasound-guided stenting for renal artery stenosis in patients with chronic renal insufficiency. Angiology 2015; 66(3): 231-6.
[http://dx.doi.org/10.1177/0003319714524297] [PMID: 24604913]
[71]
Spinosa DJ, Matsumoto AH, Angle JF, et al. Safety of CO(2)- and gadodiamide-enhanced angiography for the evaluation and percutaneous treatment of renal artery stenosis in patients with chronic renal insufficiency. AJR Am J Roentgenol 2001; 176(5): 1305-11.
[http://dx.doi.org/10.2214/ajr.176.5.1761305] [PMID: 11312200]
[72]
Adachi Y, Endo A, Nakashima R, et al. Renal artery stenting using CO2 gas angiography in combination with iodinated contrast angiography. Intern Med 2016; 55(17): 2419-22.
[http://dx.doi.org/10.2169/internalmedicine.55.6846] [PMID: 27580543]
[73]
Hasjim BJ, Fujitani RM, Chen SL, et al. Utilization of carbon dioxide angiography and percutaneous balloon angioplasty for treatment of transplant renal artery stenosis. Ann Vasc Surg 2020; 65: 10-6.
[http://dx.doi.org/10.1016/j.avsg.2019.11.009] [PMID: 31712187]
[74]
Althoff CE, Günther RW, Hamm B, Rief M. Intra-arterial ultra low iodine CT angiography of renal transplant arteries. Cardiovasc Intervent Radiol 2014; 37(4): 1062-7.
[http://dx.doi.org/10.1007/s00270-014-0838-9] [PMID: 24464257]
[75]
Szczurowska A, Banasik M, Kurcz J, et al. Intra-arterial computed tomography angiography with ultra-low volume of iodine contrast and stent implantation in transplant renal artery stenosis in terms of contrast-induced kidney injury - a preliminary report. Pol J Radiol 2020; 85: e174-7.
[http://dx.doi.org/10.5114/pjr.2020.94364] [PMID: 32419881]
[76]
Fananapazir G, Troppmann C, Corwin MT, Nikpour AM, Naderi S, Lamba R. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants. Abdom Radiol (NY) 2016; 41(11): 2182-6.
[http://dx.doi.org/10.1007/s00261-016-0827-3] [PMID: 27377897]
[77]
Cheungpasitporn W, Thongprayoon C, Mao MA, et al. Contrast-induced acute kidney injury in kidney transplant recipients: A systematic review and meta-analysis. World J Transplant 2017; 7(1): 81-7.
[http://dx.doi.org/10.5500/wjt.v7.i1.81] [PMID: 28280699]
[78]
Fananapazir G, Troppmann C, Corwin MT, Bent CK, Vu CT, Lamba R. Incidence of contrast-induced nephropathy after renal graft catheter arteriography using iodine-based contrast medium. AJR Am J Roentgenol 2016; 206(4): 783-6.
[http://dx.doi.org/10.2214/AJR.15.15501] [PMID: 26866337]
[79]
Katsiki N, Fonseca V, Mikhailidis DP. Contrast-induced acute kidney injury in diabetes mellitus: Clinical relevance and predisposing factors. Could statins be of benefit? J Diabetes Complications 2018; 32(11): 982-4.
[http://dx.doi.org/10.1016/j.jdiacomp.2018.08.008] [PMID: 30131213]
[80]
Kuźma Ł, Małyszko J, Kurasz A, et al. Impact of renal function on patients with acute coronary syndromes: 15,593 patient-years study. Ren Fail 2020; 42(1): 881-9.
[http://dx.doi.org/10.1080/0886022X.2020.1810069] [PMID: 32862755]
[81]
Gorelik Y, Bloch-Isenberg N, Heyman SN, Khamaisi M. Renal functional recovery confounding the assessment of contrast nephropathy: Propensity score analysis. Am J Nephrol 2021; 52(1): 76-83.
[http://dx.doi.org/10.1159/000513914] [PMID: 33657555]
[82]
Räty P, Mentula P, Lampela H, et al. Intravenous contrast computed tomography versus native computed tomography in patients with acute Abdomen and impaired Renal functiOn (INCARO): A multicentre, open-label, randomised controlled trial - study protocol. BMJ Open 2020; 10(10): e037928.
[http://dx.doi.org/10.1136/bmjopen-2020-037928] [PMID: 33028554]
[83]
Dekkers IA, Olchowy C, Thomsen HS, Molen AJV. Adherence to guidelines aimed at preventing post-contrast acute kidney injury (PC-AKI) in radiology practices: A survey study. Acta Radiol 2021; 62(7): 976-84.
[PMID: 32757641]
[84]
Cope LH, Drinkwater KJ, Howlett DC. RCR audit of compliance with UK guidelines for the prevention and detection of acute kidney injury in adult patients undergoing iodinated contrast media injections for CT. Clin Radiol 2017; 72(12): 1047-52.
[http://dx.doi.org/10.1016/j.crad.2017.07.002] [PMID: 28842112]
[85]
Shinkins B, Harris M, Lewington A, Abraham S, Snaith B. Kidney function testing prior to contrast-enhanced CT: A comparative cost analysis of a personalised risk-stratified pathway versus a test all approach. Clin Radiol 2021; 76(3): 202-12.
[http://dx.doi.org/10.1016/j.crad.2020.09.018] [PMID: 33109348]
[86]
Corbett M, Duarte A, Llewellyn A, et al. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: Systematic reviews and economic evaluation. Health Technol Assess 2020; 24(39): 1-248.
[http://dx.doi.org/10.3310/hta24390] [PMID: 32840478]
[87]
Becker BA, Yeich T, Jaffe JT, et al. Impact of creatinine screening on contrast-induced nephropathy following computerized tomography for stroke. Am J Emerg Med 2020; S0735-6757(20)30840-8.
[88]
Mathur N, Lu ZX, MacKay L, Lau T, Kuganesan A, Lau KK. Is point of care renal function testing reliable screening pre-IV contrast administration? Emerg Radiol 2021; 28(1): 77-82.
[http://dx.doi.org/10.1007/s10140-020-01829-7] [PMID: 32725604]
[89]
Snaith B, Harris MA, Shinkins B, et al. Point of care creatinine testing in diagnostic imaging: A feasibility study within the outpatient computed tomography setting. Eur J Radiol 2019; 112: 82-7.
[http://dx.doi.org/10.1016/j.ejrad.2019.01.007] [PMID: 30777224]
[90]
Bogaert L, Schiemsky T, Van Hover P, De Schrijver P, Van Hoovels L. Analytical and diagnostic performance evaluation of five creatinine POCT devices in the identification of patients at risk for post-contrast acute kidney injury (PCAKI). Clin Chem Lab Med 2019; 57(9): e214-7.
[http://dx.doi.org/10.1515/cclm-2018-1105] [PMID: 30710476]
[91]
Nijssen EC, Nelemans PJ, Rennenberg RJ, van der Molen AJ, van Ommen GV, Wildberger JE. Impact on clinical practice of updated guidelines on iodinated contrast material: CINART. Eur Radiol 2020; 30(7): 4005-13.
[http://dx.doi.org/10.1007/s00330-020-06719-7] [PMID: 32107605]
[92]
Nijssen EC, Nelemans PJ, Rennenberg RJ, van Ommen V, Wildberger JE. Prophylactic intravenous hydration to protect renal function from intravascular iodinated contrast material (AMACING): Long-term results of a prospective, randomised, controlled trial. EClinicalMedicine 2018; 4-5: 109-16.
[http://dx.doi.org/10.1016/j.eclinm.2018.10.007] [PMID: 31193613]
[93]
De Simone B, Ansaloni L, Sartelli M, et al. Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced computed tomography for non-traumatic acute abdomen in emergency surgery department? Acta Biomed 2018; 89(9-S): 158-72.
[PMID: 30561410]
[94]
Liu Z, Shang A, Chen Z, Yin L, Qi H. Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans. Medicine (Baltimore) 2020; 99(37): e21386.
[http://dx.doi.org/10.1097/MD.0000000000021386] [PMID: 32925711]
[95]
Wybraniec MT, Bożentowicz-Wikarek M, Chudek J, Mizia-Stec K. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography. Int J Cardiovasc Imaging 2017; 33(5): 595-604.
[http://dx.doi.org/10.1007/s10554-016-1039-1] [PMID: 27995343]
[96]
Wang W, Pang Y, Ding F. Impact of prealbumin levels on patients with acute kidney injury. Angiology 2016; 67(3): 295-6.
[http://dx.doi.org/10.1177/0003319715604266] [PMID: 26341260]
[97]
Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: A meta-analysis of observational clinical studies. Intensive Care Med 2010; 36(10): 1657-65.
[http://dx.doi.org/10.1007/s00134-010-1928-z] [PMID: 20517593]
[98]
Nakahashi T, Tada H, Sakata K, et al. Impact of concomitant peripheral artery disease on contrast-induced acute kidney injury and mortality in patients with acute coronary syndrome after percutaneous coronary intervention. Heart Vessels 2020; 35(10): 1360-7.
[http://dx.doi.org/10.1007/s00380-020-01614-z] [PMID: 32342211]
[99]
Lüders F, Malyar N, Meyborg M, Gebauer K, Brand E, Reinecke H. Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injury. Nephron Clin Pract 2012; 122(1-2): 38-43.
[http://dx.doi.org/10.1159/000346105] [PMID: 23548372]
[100]
Zhao YY, Liu DW, Wang JS, et al. [Risk factors of contrast-induced nephropathy in patients after coronary artery intervention]. Zhonghua Yi Xue Za Zhi 2012; 92(22): 1547-9. [Risk factors of contrast-induced nephropathy in patients after coronary artery intervention].
[PMID: 22944059]
[101]
Huang Y, Zhang S, Liu M, et al. Impact of RAAS blockers on contrast-induced nephropathy in patients with renal insufficiency: A meta-analysis. J Cardiovasc Pharmacol 2020; 76(6): 692-7.
[http://dx.doi.org/10.1097/FJC.0000000000000910] [PMID: 32889964]
[102]
van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR contrast medium safety committee guidelines. Eur Radiol 2018; 28(7): 2845-55.
[http://dx.doi.org/10.1007/s00330-017-5246-5] [PMID: 29426991]
[103]
Pelisek J, Assadian A, Sarkar O, Eckstein HH, Frank H. Carotid plaque composition in chronic kidney disease: A retrospective analysis of patients undergoing carotid endarterectomy. Eur J Vasc Endovasc Surg 2010; 39(1): 11-6.
[http://dx.doi.org/10.1016/j.ejvs.2009.09.024] [PMID: 19906548]
[104]
Wanhainen A, Verzini F, Van Herzeele I, et al. Editor’s choice - European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg 2019; 57(1): 8-93.
[http://dx.doi.org/10.1016/j.ejvs.2018.09.020] [PMID: 30528142]
[105]
Naylor AR, Ricco JB, de Borst GJ, et al. Editor’s choice - management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018; 55(1): 3-81.
[http://dx.doi.org/10.1016/j.ejvs.2017.06.021] [PMID: 28851594]
[106]
Aboyans V, Björck M, Brodmann M, et al. Questions and answers on diagnosis and management of patients with peripheral arterial diseases: A companion document of the 2017 ESC guidelines for the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018; 55(4): 457-64.
[http://dx.doi.org/10.1016/j.ejvs.2017.08.014] [PMID: 29628287]
[107]
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation 2011; 124(23): e574-651.
[PMID: 22064601]
[108]
Available from: https://www.acr.org/-/media/ACR/files/clinical-resources/contrast_media.pdf
[109]
Nijssen EC, Rennenberg R, Nelemans P, van Ommen V, Wildberger JE. Post-contrast acute kidney injury and intravenous prophylactic hydration: An Update. Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 2021; 193(2): 151-9.
[http://dx.doi.org/10.1055/a-1248-9178] [PMID: 33327033]
[110]
Davenport MS, Perazella MA, Yee J, et al. Use of intravenous iodinated contrast media in patients with kidney disease: Consensus statements from the American college of radiology and the national kidney foundation. Kidney Med 2020; 2(1): 85-93.
[http://dx.doi.org/10.1016/j.xkme.2020.01.001] [PMID: 33015613]
[111]
van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury. Part 2: Risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 2018; 28(7): 2856-69.
[http://dx.doi.org/10.1007/s00330-017-5247-4] [PMID: 29417249]
[112]
Sebastià C, Páez-Carpio A, Guillen E, et al. Oral hydration compared to intravenous hydration in the prevention of post-contrast acute kidney injury in patients with chronic kidney disease stage IIIb: A phase III non-inferiority study (NICIR study). Eur J Radiol 2021; 136: 109509.
[http://dx.doi.org/10.1016/j.ejrad.2020.109509] [PMID: 33516141]
[113]
Elisaf M, Mikhailidis DP. Statins and renal function. Angiology 2002; 53(5): 493-502.
[http://dx.doi.org/10.1177/000331970205300501] [PMID: 12365855]
[114]
Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg 2006; 32(3): 286-93.
[http://dx.doi.org/10.1016/j.ejvs.2006.03.009] [PMID: 16690330]
[115]
Paraskevas KI, Veith FJ, Liapis CD, Mikhailidis DP. Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: An update. Curr Vasc Pharmacol 2013; 11(1): 112-20.
[http://dx.doi.org/10.2174/157016113804547656] [PMID: 22272894]
[116]
Ahmed K, McVeigh T, Cerneviciute R, et al. Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis. BMC Nephrol 2018; 19(1): 323.
[http://dx.doi.org/10.1186/s12882-018-1113-0] [PMID: 30424723]
[117]
Bellos I, Iliopoulos DC, Perrea DN. Allopurinol administration for the prevention of contrast-induced nephropathy: A network meta-analysis with trial sequential analysis. J Cardiovasc Pharmacol 2019; 73(5): 307-15.
[http://dx.doi.org/10.1097/FJC.0000000000000663] [PMID: 30829731]
[118]
Rancic ZS. Commentary on ‘contrast induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease’. Eur J Vasc Endovasc Surg 2016; 51(3): 394.
[http://dx.doi.org/10.1016/j.ejvs.2015.12.013] [PMID: 26818023]
[119]
Navin P, Murray AM, Nandikumar K, Waldron R, Tuohy B, Casey M. Shaped-bolus protocol reduces contrast medium volume in abdominal CT while maintaining image quality. Clin Radiol 2017; 72(3): 265.e1-5.
[http://dx.doi.org/10.1016/j.crad.2016.10.011] [PMID: 27884388]
[120]
Young LK, Matthew SZ, Houston JG. Absence of potential gadolinium toxicity symptoms following 22,897 gadoteric acid (Dotarem®) examinations, including 3,209 performed on renally insufficient individuals. Eur Radiol 2019; 29(4): 1922-30.
[http://dx.doi.org/10.1007/s00330-018-5737-z] [PMID: 30276674]
[121]
Karlsberg RP, Dohad SY, Sheng R. Contrast medium-induced acute kidney injury: Comparison of intravenous and intraarterial administration of iodinated contrast medium. J Vasc Interv Radiol 2011; 22(8): 1159-65.
[http://dx.doi.org/10.1016/j.jvir.2011.03.020] [PMID: 21570871]
[122]
Andò G, Gragnano F, Calabrò P, Valgimigli M. Radial vs femoral access for the prevention of acute kidney injury (AKI) after coronary angiography or intervention: A systematic review and meta-analysis. Catheter Cardiovasc Interv 2018; 92(7): E518-26.
[http://dx.doi.org/10.1002/ccd.27903] [PMID: 30244540]

Rights & Permissions Print Cite
Article Metrics
31
2
© 2024 Bentham Science Publishers | Privacy Policy